Key result
The 2019 ESC guidelines redefine stable coronary artery disease as chronic coronary syndromes, emphasizing clinical likelihood assessment, coronary CTA, and individualized management.
The 2019 ESC guidelines reclassify stable coronary artery disease into chronic coronary syndromes to reflect its dynamic, progressive nature and emphasize clinical likelihood assessment, noninvasive coronary CT angiography, and individualized therapy.
Coronary artery disease (CAD) is a chronic, progressive affliction that leads to atherosclerotic plaque development and progression within the epicardial coronary arteries. Being a dynamic process, CAD generally presents with a prolonged stable phase, which may suddenly become unstable and lead to an acute coronary event. Thus, the concept of stable CAD may be misleading, as the risk for secondary events continues to exist, despite the increasing use of optimal pharmacological therapies, lifestyle modifications, and myocardial revascularization procedures.1 The 2019 guidelines of the European Society of Cardiology (ESC) for CAD have introduced a concept that categorizes the disease according to its clinical presentation into acute or chronic coronary syndromes (ACS and CCS, respectively). Previously defined as stable angina pectoris, CCS includes nowadays a heterogeneous population with or without anginal symptoms, with or without prior acute coronary syndromes, and with or without previous coronary revascularization procedures.2
No takes yet. Share an insight, caveat, or question.
Diana Opincariu (2019) conducted an editorial in Chronic coronary syndromes (stable coronary artery disease). The 2019 ESC guidelines redefine stable coronary artery disease as chronic coronary syndromes, emphasizing clinical likelihood assessment, coronary CTA, and individualized management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: